167 related articles for article (PubMed ID: 38326908)
21. ANKHD1 is required for SMYD3 to promote tumor metastasis in hepatocellular carcinoma.
Zhou Z; Jiang H; Tu K; Yu W; Zhang J; Hu Z; Zhang H; Hao D; Huang P; Wang J; Wang A; Xiao Z; He C
J Exp Clin Cancer Res; 2019 Jan; 38(1):18. PubMed ID: 30646949
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-1468 promotes tumor progression by activating PPAR-γ-mediated AKT signaling in human hepatocellular carcinoma.
Liu Z; Wang Y; Dou C; Sun L; Li Q; Wang L; Xu Q; Yang W; Liu Q; Tu K
J Exp Clin Cancer Res; 2018 Mar; 37(1):49. PubMed ID: 29510736
[TBL] [Abstract][Full Text] [Related]
23. MEX3C-Mediated Decay of SOCS3 mRNA Promotes JAK2/STAT3 Signaling to Facilitate Metastasis in Hepatocellular Carcinoma.
Xiao Y; Li Y; Shi D; Wang X; Dai S; Yang M; Kong L; Chen B; Huang X; Lin C; Liao W; Xu B; Chen X; Wang L; Chen X; Ouyang Y; Liu G; Li H; Song L
Cancer Res; 2022 Nov; 82(22):4191-4205. PubMed ID: 36112698
[TBL] [Abstract][Full Text] [Related]
24. Lysyl oxidase-like 2 (LOXL2) controls tumor-associated cell proliferation through the interaction with MARCKSL1.
Kim BR; Dong SM; Seo SH; Lee JH; Lee JM; Lee SH; Rho SB
Cell Signal; 2014 Sep; 26(9):1765-73. PubMed ID: 24863880
[TBL] [Abstract][Full Text] [Related]
25. LncRNA DARS-AS1 aggravates the growth and metastasis of hepatocellular carcinoma via regulating the miR-3200-5p-Cytoskeleton associated protein 2 (CKAP2) axis.
Feng Y; Wei G; Zhang L; Zhou H; Wang W; Guo P; Cheng C; Ji L; Cai Q; Feng Y; Tu H
Bioengineered; 2021 Dec; 12(1):8217-8232. PubMed ID: 34596006
[TBL] [Abstract][Full Text] [Related]
26. Significance of Lysyl oxidase‑like 2 gene expression on the epithelial‑mesenchymal status of hepatocellular carcinoma.
Ninomiya G; Yamada S; Hayashi M; Takeda S; Suenaga M; Takami H; Kanda M; Iwata N; Niwa Y; Tanaka C; Kobayashi D; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Oncol Rep; 2018 Jun; 39(6):2664-2672. PubMed ID: 29620290
[TBL] [Abstract][Full Text] [Related]
27. Multiple Roles of LOXL2 in the Progression of Hepatocellular Carcinoma and Its Potential for Therapeutic Targeting.
Radić J; Kožik B; Nikolić I; Kolarov-Bjelobrk I; Vasiljević T; Vranjković B; Despotović S
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511503
[TBL] [Abstract][Full Text] [Related]
28. LncRNA DBH-AS1 facilitates the tumorigenesis of hepatocellular carcinoma by targeting miR-138 via FAK/Src/ERK pathway.
Bao J; Chen X; Hou Y; Kang G; Li Q; Xu Y
Biomed Pharmacother; 2018 Nov; 107():824-833. PubMed ID: 30142544
[TBL] [Abstract][Full Text] [Related]
29. Hypoxia-induced lncRNA MRVI1-AS1 accelerates hepatocellular carcinoma progression by recruiting RNA-binding protein CELF2 to stabilize SKA1 mRNA.
Tuo H; Liu R; Wang Y; Yang W; Liu Q
World J Surg Oncol; 2023 Mar; 21(1):111. PubMed ID: 36973749
[TBL] [Abstract][Full Text] [Related]
30. Identification of a novel lysyl oxidase-like 2 alternative splicing isoform, LOXL2 Δe13, in esophageal squamous cell carcinoma.
Lv GQ; Zou HY; Liao LD; Cao HH; Zeng FM; Wu BL; Xie JJ; Fang WK; Xu LY; Li EM
Biochem Cell Biol; 2014 Oct; 92(5):379-89. PubMed ID: 25275797
[TBL] [Abstract][Full Text] [Related]
31. Long non-coding RNA linc-ITGB1 promotes cell proliferation, migration, and invasion in human hepatoma carcinoma by up-regulating ROCK1.
Huang L; Li X; Gao W
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30279202
[No Abstract] [Full Text] [Related]
32. Correction: RNA-binding protein RPS7 promotes hepatocellular carcinoma progression via LOXL2-dependent activation of ITGB1/FAK/SRC signaling.
Zhou YJ; Yang ML; He X; Gu HY; Ren JH; Cheng ST; Fu Z; Zhang ZZ; Chen J
J Exp Clin Cancer Res; 2024 Mar; 43(1):80. PubMed ID: 38481346
[No Abstract] [Full Text] [Related]
33. Deubiquitinase ZRANB1 drives hepatocellular carcinoma progression through SP1-LOXL2 axis.
Li Q; Chao Q; Liu Y; Fang J; Xie J; Zhen J; Ding Y; Fu B; Ke Y; Xiao F; Wu H; Huang Z; Hao H; Huang D
Am J Cancer Res; 2021; 11(10):4807-4825. PubMed ID: 34765294
[TBL] [Abstract][Full Text] [Related]
34. Long non-coding RNA MAPKAPK5-AS1/PLAGL2/HIF-1α signaling loop promotes hepatocellular carcinoma progression.
Wang L; Sun L; Liu R; Mo H; Niu Y; Chen T; Wang Y; Han S; Tu K; Liu Q
J Exp Clin Cancer Res; 2021 Feb; 40(1):72. PubMed ID: 33596983
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK/AKT signaling in hepatocellular carcinoma.
Chen JS; Li HS; Huang JQ; Dong SH; Huang ZJ; Yi W; Zhan GF; Feng JT; Sun JC; Huang XH
Cancer Lett; 2016 May; 375(1):73-83. PubMed ID: 26944318
[TBL] [Abstract][Full Text] [Related]
36. Upregulation of a novel LncRNA AC104958.2 stabilized by PCBP2 promotes proliferation and microvascular invasion in hepatocellular carcinoma.
Ma Z; Li S; Wang Y; Zhang J; Zeng X
Exp Cell Res; 2021 Oct; 407(1):112791. PubMed ID: 34418457
[TBL] [Abstract][Full Text] [Related]
37. LncRNA CARMN Affects Hepatocellular Carcinoma Prognosis by Regulating the miR-192-5p/LOXL2 Axis.
Wang X; Wu S; Yang Y; Zhao J
Oxid Med Cell Longev; 2022; 2022():9277360. PubMed ID: 36254230
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA‑9‑5p downregulates Klf4 and influences the progression of hepatocellular carcinoma via the AKT signaling pathway.
Dong X; Wang F; Xue Y; Lin Z; Song W; Yang N; Li Q
Int J Mol Med; 2019 Mar; 43(3):1417-1429. PubMed ID: 30664155
[TBL] [Abstract][Full Text] [Related]
39. Increased Expression of the Matrix-Modifying Enzyme Lysyl Oxidase-Like 2 in Aggressive Hepatocellular Carcinoma with Poor Prognosis.
Choi J; Chung T; Rhee H; Kim YJ; Jeon Y; Yoo JE; Noh S; Han DH; Park YN
Gut Liver; 2019 Jan; 13(1):83-92. PubMed ID: 29938458
[TBL] [Abstract][Full Text] [Related]
40. The long non-coding RNA PTTG3P promotes cell growth and metastasis via up-regulating PTTG1 and activating PI3K/AKT signaling in hepatocellular carcinoma.
Huang JL; Cao SW; Ou QS; Yang B; Zheng SH; Tang J; Chen J; Hu YW; Zheng L; Wang Q
Mol Cancer; 2018 May; 17(1):93. PubMed ID: 29803224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]